POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS

18/11/2013
14/03/2024
EU PAS number:
EUPAS5184
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

cv185102st-prot (pfizer-protocol-b0661018)

English (123.8 KB - PDF) View document
Updated protocol

cv185102st-prot-may2015-(pfizer-protocol-b0661018)-red

First published: 22/02/2024
English (1.7 MB - PDF) View document
Study results
Study results

study-cv185102st-csr-final-red

English (1000.57 KB - PDF) View document
Study report
Other information